We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Hits WalkMed With Warning Letter for Failing to Investigate Complaints
FDA Hits WalkMed With Warning Letter for Failing to Investigate Complaints
Failure to conduct adequate investigations of complaints related to its volumetric infusion pumps and not providing corrective action documents are among the issues that have landed WalkMed Infusion an FDA warning letter.